Outpatient Therapies Physicians Special Programs Patient Conditions Rehabilitation Orthopaedics

 
 

Kernan Hospital

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Ask Our Experts

Get answers to your specific medical questions from Kernan Hospital experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Kernan Hospital

Our Services

Patient Success Stories

Our Doctors

Alpha-1 antitrypsin deficiency - Overview

Alternative Names

AAT deficiency

Definition of Alpha-1 antitrypsin deficiency:

Alpha-1 antitrypsin deficiency is a lack of a liver protein that blocks the destructive effects of certain enzymes. The condition may lead to emphysema and liver disease, and in rare cases, skin disease.

Causes, incidence, and risk factors:

Alpha-1 antitrypsin deficiency results from a genetic defect. The mechanism that causes associated liver disease and emphysema in some people with this deficiency is not known. However, some evidence suggests that it may be related to inflammation.

Studies now show that Alpha-1 antitrypsin deficiency may be more common than once thought. Approximately 75% of adults with severe deficiency will develop emphysema, which often begins before 40 years of age. Smoking can increase the risk.

  • Reviewed last on: 3/1/2007
  • David A. Kaufman, M.D., Assistant Professor, Division of Pulmonary Medicine, Mount Sinai School of Medicine, New York, NY. Review provided by VeriMed Healthcare Network.

References

Perlmutter, DH. Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis. November 2004;8:839-859.

Stoller JK, Tomashefski J, Crystal RG, et al. Mortality in individuals with severe deficiency of alpha-1-antitrypsin: Findings from the National Heart, Lung, and Blood Institute Registry. Chest. April 2005;127:1196-1204.

Physicians Special Programs Patient Conditions Physical Therapy